Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease (Q40659360)

22 September 2017

title

Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease (English)

1 reference

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tracy A Delaney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Chris Morehouse

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Yihong Yao

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Miguel Sanjuan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

25 May 2016

1 reference

22 September 2017

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

42-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

Cellular and molecular aspects of vascular dysfunction in systemic sclerosis

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Scleroderma, fibroblasts, signaling, and excessive extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Type I interferons (alpha/beta) in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Discovering statistically significant pathways in expression profiling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Type 1 interferons and myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferon-lambda: a new addition to an old family

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferons as pathogenic effectors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Autoimmunity through cytokine-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Recombination activating gene-2 regulates CpG-mediated interferon-α production in mouse bone marrow-derived plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

What are the roles of metalloproteinases in cartilage and bone damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

MMP9 modulates tight junction integrity and cell viability in human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Klf10 and Klf11 as mediators of TGF-beta superfamily signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

Antiproliferative action of interferon-α requires components of T-cell-receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502190

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1502190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226090%20AND%20SRC:MED&resulttype=core&format=json